Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

InCarda announces progress in development program for InRhythm

June 10, 2021

Arena begins phase II study of temanogrel for coronary microvascular obstruction

June 9, 2021

Epeleuton shows efficacy in preclinical models of atherosclerosis

June 3, 2021

ATTR removal observed in vitro and in vivo with NI-006

June 3, 2021

Researchers develop new model of extracorporeal membrane oxygenation thrombosis

June 3, 2021

CIDEC gene silencing ameliorates experimental diabetic cardiomyopathy

June 3, 2021

Phase I data for anti-PCSK9 peptide vaccine candidates AT-04A and AT-06A

June 1, 2021

Bayer presents new alpha2C-adrenoceptor antagonists

June 1, 2021

Ziltivekimab reduces biomarkers of inflammation and thrombosis in phase II RESCUE study

May 31, 2021

Activation of MT2 reduces cardiac I/R injury in prediabetic rats

May 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...